PROGESTERONE

Product Description

Niksan Pharmaceutical is one of the most leading manufacturer, supplier, distributer and exporter of Progesterone API and finished formulation as all dosage form like solution and intramuscular injection. Our product Progesterone is widely used and appreciated by our group companies and also our customers and users all around the nations. We offer the Progesterone in very affordable price.

Niksan Pharmaceutical is the supplier, manufacturer, exporter and trader in the domestic level as well as the international market.  

Niksan Pharmaceutical provides API and finished formulations of Progesterone in all over Indian states like Nagaland, Jammu & Kashmir, Pondicherry, Kerala, Tamil Nadu, Uttara khand, Telangana, Himachal Pradesh, Goa, Karnataka, Manipur, Meghalaya, Punjab, Haryana, Chhattisgarh, Maharashtra, Gujarat, Chandigarh, Delhi, Odisha, Assam, West Bengal, Rajasthan, Madhya Pradesh, Bihar etc.

Niksan pharmaceutical is also large exporters of the API and finished pharmaceutical products of Progesterone in many countries for years. The countries where we exporting are United States, Nigeria, Australia, Italy, Ghana, New Zealand, Ireland, Canada, South Africa, Lebanon, Kenya, Singapore, United Arab Emirates, Sri Lanka, Algeria, Pakistan, France, Malaysia, Hong Kong, Bangladesh, Switzerland, Egypt, Morocco, Belgium, Vietnam, Greece, South Korea, Hungary, Thailand, Sweden, Iran, Romania and many other countries.

Progesterone is used to treatment of gynaecological disorders and also used in women to support pregnancy and fertility.

SYNONYMS: (S)-Progesterone, 17alpha-Progesterone, Agolutin, Akrolutin, Corpus Luteum Hormone, Gelbkrperhormon, Luteohormone, Lutogynon, Progesteron, Progesterona, Progestrone, Progesterone, Progesteronum

IUPAC NAME:(1S,3aS,3bS,9aR,9bS,11aS)-1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one

CAS NO: 57-83-0

FORMULA:C21H30O2

MOLECULAR MASS: 314.46g/mol

STORAGE OF Progesterone: Store in cool and dry place. Do not put in bathroom or kitchen.Do not use Progesterone after the expiration.

APPLICATIONS OF PROGESTERONE: Progesterone is used to treatment of gynaecological disorders and also used in women to support pregnancy andfertility. Progesterone is used in combination with the hormone estrogen to "oppose estrogen" as part of hormone replacement therapy.

HOWTO USE: Progesterone sold in market as a capsule form so you can take this medicine by mouth. It is generally taken once a day in the evening or at bedtime.

HOW PROGESTERONE WORKS: Progesterone prepares the endometrial for the potential of pregnancy after ovulation.

CONTRAINDICATIONS: If you are a patient of breast cancer or diabetes kindly avoid this drug. Kindly avoid this medication if you have a high blood pressure problem anddepression.Do not take this medication if you a patient of liver disease and liver tumour. If you have a coronary artery disease and clot in the lung kindly avoid Progesterone.

PHARMACOKINETICS OF PROGESTERONE: After oral administration Progesterone metabolized mainly in liver. Half-life of Progesterone is approximately 25 to 50 hours. Peak plasma concentration of Progesterone is 6.5to 10.2 mg/ml. Progesteron is mainly excreted by kidney and urine.

SIDEEFFECTS OF Progesterone: Most common side effect of Progesteron is Headache, Vision changes, Vertigo, Low blood pressure, Changes in heart rate, Coughing, Depression, Fatigue, Menstrual changes, Confusion and Difficulty in breathing. Other side effects of Progesteron is allergic reaction like Skin rash or itchy skin, Tightness in the chest, tingling in the mouth or throat, Trouble breathing, Swelling in the hands or face.

PRECAUTION: Consult with your doctor if you have pain in the chest, groin or legs. Stop using Progesterone if you have sudden difficulty with breathing or unexplained shortness of breath.

CDSCO APPROVAL: Norgestrel +hydroxy progesterone + norethisterone + acetoxy progesterone January-1969

Isopregnenone, dydrogestrone tablet is approved by CDSCO in India in Auust-1962

Medroxyprogesterone acetate tablet is approved by CDSCO in India in June-1986

Progesterone micronized soft gelatine capsule is approved by CDSCO in India in 21.06.1995

Medroxyprogesterone acetate suspension for injection, Single dose container with 104mgMedroxyprogesterone acetate in 0.65 ml suspension for injection (SAYNA PRESS) (Additional route/ strength/indication) is approved by CDSCO in India in18.12.2014

Lynestrenol tablet is approved by CDSCO in India in January-1964

Progesterone pessary tablet is approved by CDSCO in India in 25.10.2001

FORMULATIONS AVAILABLE IN MARKET:

Progesterone25 MG /ML Injections

Progesterone50 MG /ML Injections

Progesterone300 MG Tablets

Progesterone200 MG Tablets

Progesterone100 MG Tablets

Progesterone400 MG Tablets

Progesterone100 MG /ML Injections

Progesterone200 MG /ML Injections

Progesterone22.35 MG /ML Injections

Progesterone12.5 %W/V /ML Injections

L-methylfolate500 MCG+Progesterone 200 MG Tablets

Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk.

REFERENCES:

www.webmd.com

https://pubchem.ncbi.nlm.nih.gov

https://go.drugbank.com

https://cdscoonline.gov.in

https://www.wikipedia.org/

https://www.drugs.com

https://www.zaubacorp.com

https://www.practo.com/consult